Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Genesystem Co., Ltd. (363250:KRX), powered by AI.
Genesystem Co., Ltd. is currently trading at ₩6,800. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Genesystem Co., Ltd. on Alpha Lenz.
Genesystem Co., Ltd.'s P/E ratio is -5.2.
“Genesystem Co., Ltd. trades at a P/E of -5.2 (undervalued) with modest ROE of -38.2%.”
Ask for details →Genesystem Co., Ltd. is a biotechnology company specializing in the development and commercialization of innovative diagnostic solutions. The primary focus of the company is to provide advanced molecular diagnostic systems that assist in the rapid and accurate detection of various diseases. Notably, the company has expanded its expertise into areas like infectious diseases, genetic disorders, and cancer diagnostics, providing healthcare professionals with essential tools for early intervention and precise treatment strategies. Its contributions are pivotal in enhancing the capabilities of laboratories and hospitals by streamlining diagnostic workflows and improving patient outcomes. Headquartered in South Korea, Genesystem Co., Ltd. stands out in the biotechnology industry for its commitment to research and development, consistently pushing the boundaries of diagnostic technologies in the global healthcare market.
“Genesystem Co., Ltd. trades at a P/E of -5.2 (undervalued) with modest ROE of -38.2%.”
Ask for details →